CD molecules
Specialist advisors:
External resource: HCDM Human Cell Differentiation Molecules oganisation (HLA8 to HCDM)
Click on the Approved Gene Symbol to retrieve the complete gene record, click here for the CD molecules sorted by Approved Gene Symbol.
| Approved Symbol | Approved Name | Previous Symbols | Synonyms | Chromosome |
|---|---|---|---|---|
| CD1A | CD1a molecule | CD1 | 1q22-q23 | |
| CD1B | CD1b molecule | CD1 | 1q22-q23 | |
| CD1C | CD1c molecule | CD1 | 1q22-q23 | |
| CD1D | CD1d molecule | 1q22-q23 | ||
| CD1E | CD1e molecule | 1q22-q23 | ||
| CD2 | CD2 molecule | SRBC | 1p13 | |
| CD3D | CD3d molecule, delta (CD3-TCR complex) | T3D | 11q23 | |
| CD3E | CD3e molecule, epsilon (CD3-TCR complex) | 11q23 | ||
| CD3G | CD3g molecule, gamma (CD3-TCR complex) | 11q23 | ||
| CD4 | CD4 molecule | 12p13.31 | ||
| CD5 | CD5 molecule | LEU1 | T1 | 11q13 |
| CD6 | CD6 molecule | Tp120 | 11q12.2 | |
| CD7 | CD7 molecule | GP40, LEU-9, TP41, Tp40 | 17q25.2-q25.3 | |
| CD8A | CD8a molecule | CD8 | 2p12 | |
| CD8B | CD8b molecule | CD8B1 | 2p12 | |
| CD9 | CD9 molecule | MIC3 | BA2, P24, TSPAN29, MRP-1 | 12p13 |
| MME | membrane metallo-endopeptidase | CALLA, CD10, NEP | 3q25.2 | |
| ITGAL | integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide) | CD11A | LFA-1 | 16p13.1-p11 |
| ITGAM | integrin, alpha M (complement component 3 receptor 3 subunit) | CR3A, CD11B | MAC-1, CD11b | 16p11.2 |
| ITGAX | integrin, alpha X (complement component 3 receptor 4 subunit) | CD11C | CD11c | 16p11.2 |
| ITGAD | integrin, alpha D | CD11d, ADB2 | 16p13.1-p11 | |
| ANPEP | alanyl (membrane) aminopeptidase | CD13, PEPN | LAP1, gp150, p150 | 15q25-q26 |
| CD14 | CD14 molecule | 5q31.3 | ||
| FUT4 | fucosyltransferase 4 (alpha (1,3) fucosyltransferase, myeloid-specific) | CD15, FCT3A, ELFT | FUC-TIV | 11q21 |
| FCGR3A | Fc fragment of IgG, low affinity IIIa, receptor (CD16a) | FCGR3, FCG3 | CD16, CD16a | 1q23 |
| FCGR3B | Fc fragment of IgG, low affinity IIIb, receptor (CD16b) | FCGR3, FCG3 | CD16, CD16b | 1q23 |
| ITGB2 | integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) | CD18, MFI7 | LFA-1, MAC-1 | 21q22.3 |
| CD19 | CD19 molecule | 16p11.2 | ||
| MS4A1 | membrane-spanning 4-domains, subfamily A, member 1 | CD20 | B1, Bp35, MS4A2 | 11q12-q13.1 |
| CR2 | complement component (3d/Epstein Barr virus) receptor 2 | CD21 | 1q32 | |
| CD22 | CD22 molecule | SIGLEC-2, SIGLEC2 | 19q13.1 | |
| FCER2 | Fc fragment of IgE, low affinity II, receptor for (CD23) | CD23A, FCE2 | CLEC4J, CD23 | 19p13.3 |
| CD24 | CD24 molecule | CD24A | 6q21 | |
| IL2RA | interleukin 2 receptor, alpha | IL2R | CD25 | 10p15-p14 |
| DPP4 | dipeptidyl-peptidase 4 | CD26, ADCP2 | DPPIV | 2q23-qter |
| CD27 | CD27 molecule | TNFRSF7 | S152, Tp55 | 12p13 |
| CD28 | CD28 molecule | 2q33 | ||
| ITGB1 | integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12) | FNRB, MSK12, MDF2 | CD29, GPIIA | 10p11.2 |
| TNFRSF8 | tumor necrosis factor receptor superfamily, member 8 | CD30, D1S166E | KI-1 | 1p36 |
| TNFSF8 | tumor necrosis factor (ligand) superfamily, member 8 | CD30LG | CD153 | 9q33 |
| PECAM1 | platelet/endothelial cell adhesion molecule 1 | CD31 | 17q23.3 | |
| FCGR2A | Fc fragment of IgG, low affinity IIa, receptor (CD32) | FCG2, FCGR2A1, FCGR2 | CD32, CD32A, IGFR2, CDw32 | 1q23 |
| FCGR2B | Fc fragment of IgG, low affinity IIb, receptor (CD32) | FCG2, FCGR2 | CD32, CD32B | 1q23 |
| FCGR2C | Fc fragment of IgG, low affinity IIc, receptor for (CD32) (gene/pseudogene) | hFcRII-C, CD32C | 1q23 | |
| CD33 | CD33 molecule | SIGLEC3, SIGLEC-3, p67, FLJ00391 | 19q13.3 | |
| SIGLEC6 | sialic acid binding Ig-like lectin 6 | CD33L, CD33L1 | OB-BP1, SIGLEC-6, CD327 | 19q13.3 |
| SIGLEC5 | sialic acid binding Ig-like lectin 5 | CD33L2 | OB-BP2, SIGLEC-5, CD170 | 19q13.41 |
| CD34 | CD34 molecule | 1q32 | ||
| CR1 | complement component (3b/4b) receptor 1 (Knops blood group) | CD35, KN | 1q32 | |
| CD36 | CD36 molecule (thrombospondin receptor) | SCARB3, GPIV, FAT, GP4, GP3B | 7q11.2 | |
| CD37 | CD37 molecule | TSPAN26 | 19p13-q13.4 | |
| CD38 | CD38 molecule | 4p15.32 | ||
| ENTPD1 | ectonucleoside triphosphate diphosphohydrolase 1 | CD39 | NTPDase-1, ATPDase | 10q23.1-q24.1 |
| CD40 | CD40 molecule, TNF receptor superfamily member 5 | TNFRSF5 | p50, Bp50 | 20q12-q13.2 |
| CD40LG | CD40 ligand | HIGM1, IMD3, TNFSF5 | CD40L, TRAP, gp39, hCD40L, CD154 | Xq26 |
| ITGA2B | integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41) | GP2B | CD41B, CD41 | 17q21.32 |
| GP9 | glycoprotein IX (platelet) | CD42a, GPIX | 3q21.3 | |
| GP1BA | glycoprotein Ib (platelet), alpha polypeptide | GP1B | CD42b | 17pter-p12 |
| GP1BB | glycoprotein Ib (platelet), beta polypeptide | CD42c | 22q11.21-q11.23 | |
| GP5 | glycoprotein V (platelet) | CD42d | 3q29 | |
| SPN | sialophorin | LSN, CD43, GPL115 | 16p11.2 | |
| CD44 | CD44 molecule (Indian blood group) | MIC4, MDU2, MDU3 | IN, MC56, Pgp1, CD44R, HCELL, CSPG8 | 11p13 |
| PTPRC | protein tyrosine phosphatase, receptor type, C | CD45 | LCA, T200, GP180 | 1q31-q32 |
| CD46 | CD46 molecule, complement regulatory protein | MIC10, MCP | TRA2.10, MGC26544, TLX | 1q32 |
| CD47 | CD47 molecule | MER6 | IAP, OA3 | 3q13.1-q13.2 |
| CD48 | CD48 molecule | BCM1 | BLAST, mCD48, hCD48, SLAMF2 | 1q21.3-q22 |
| ITGA1 | integrin, alpha 1 | VLA1, CD49a | 5q11.1 | |
| ITGA2 | integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor) | CD49B | CD49b | 5q11.2 |
| ITGA3 | integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor) | MSK18 | CD49c, VLA3a, VCA-2, GAP-B3 | 17q21.33 |
| ITGA4 | integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor) | CD49D | CD49d | 2q31-q32 |
| ITGA5 | integrin, alpha 5 (fibronectin receptor, alpha polypeptide) | FNRA | CD49e | 12q11-q13 |
| ITGA6 | integrin, alpha 6 | CD49f | 2q31.1 | |
| ICAM3 | intercellular adhesion molecule 3 | CDW50, ICAM-R, CD50 | 19p13.3-p13.2 | |
| ITGAV | integrin, alpha V | VNRA, MSK8, VTNR | CD51 | 2q31-q32 |
| CD52 | CD52 molecule | CDW52 | 1p36 | |
| CD53 | CD53 molecule | MOX44 | TSPAN25 | 1p13 |
| ICAM1 | intercellular adhesion molecule 1 | BB2, CD54 | 19p13.3-p13.2 | |
| CD55 | CD55 molecule, decay accelerating factor for complement (Cromer blood group) | DAF | CR, TC, CROM | 1q32 |
| NCAM1 | neural cell adhesion molecule 1 | NCAM, CD56 | 11q23.2 | |
| B3GAT1 | beta-1,3-glucuronyltransferase 1 (glucuronosyltransferase P) | CD57, LEU7 | GlcAT-P, HNK-1, NK-1 | 11q25 |
| CD58 | CD58 molecule | LFA3 | 1p13 | |
| CD59 | CD59 molecule, complement regulatory protein | MIC11, MIN1, MSK21, MIN2, MIN3 | 16.3A5, EJ16, EJ30, EL32, G344, p18-20 | 11p13 |
| ITGB3 | integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) | GP3A | CD61, GPIIIa | 17q21.32 |
| SELE | selectin E | ELAM1, ELAM | ESEL, CD62E | 1q22-q25 |
| SELL | selectin L | LYAM1, LNHR | LSEL, LAM1, LAM-1, hLHRc, Leu-8, Lyam-1, PLNHR, CD62L | 1q23-q25 |
| SELP | selectin P (granule membrane protein 140kDa, antigen CD62) | GRMP | CD62, PSEL, PADGEM, GMP140, CD62P | 1q22-q25 |
| CD63 | CD63 molecule | MLA1 | ME491, TSPAN30 | 12q12-q13 |
| FCGR1A | Fc fragment of IgG, high affinity Ia, receptor (CD64) | CD64, CD64A | 1q21.2-q21.3 | |
| CEACAM1 | carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein) | BGP | BGP1, CD66a | 19q13.2 |
| CEACAM8 | carcinoembryonic antigen-related cell adhesion molecule 8 | CGM6 | CD66b | 19q13.2 |
| CEACAM6 | carcinoembryonic antigen-related cell adhesion molecule 6 (non-specific cross reacting antigen) | NCA | CD66c | 19q13.1-q13.2 |
| CEACAM3 | carcinoembryonic antigen-related cell adhesion molecule 3 | CGM1 | CD66d | 19q13.2 |
| CEACAM5 | carcinoembryonic antigen-related cell adhesion molecule 5 | CEA | CD66e | 19q13.1-q13.2 |
| PSG1 | pregnancy specific beta-1-glycoprotein 1 | PSBG1 | PSGGA, CD66f, PBG1 | 19q13.2 |
| CD68 | CD68 molecule | SCARD1, macrosialin, GP110, DKFZp686M18236, LAMP4 | 17p13 | |
| CD69 | CD69 molecule | CLEC2C | 12p13 | |
| CD70 | CD70 molecule | CD27LG, TNFSF7 | CD27L | 19p13 |
| TFRC | transferrin receptor (p90, CD71) | CD71, TFR1 | 3q26.2-qter | |
| CD72 | CD72 molecule | LYB2, CD72b | 9p | |
| NT5E | 5'-nucleotidase, ecto (CD73) | NT5 | CD73, eN, eNT | 6q14-q21 |
| CD74 | CD74 molecule, major histocompatibility complex, class II invariant chain | DHLAG | 5q32 | |
| CD79A | CD79a molecule, immunoglobulin-associated alpha | IGA | MB-1 | 19q13.2 |
| CD79B | CD79b molecule, immunoglobulin-associated beta | IGB | B29 | 17q23 |
| CD80 | CD80 molecule | CD28LG, CD28LG1 | B7.1, B7-1 | 3q13.3-q21 |
| CD81 | CD81 molecule | TAPA1 | TAPA-1, TSPAN28 | 11pter-p11.2 |
| IGSF8 | immunoglobulin superfamily, member 8 | CD81P3, EWI2, PGRL, CD316 | 1q23.1 | |
| CD82 | CD82 molecule | ST6, KAI1 | R2, IA4, TSPAN27 | 11p11.2 |
| CD83 | CD83 molecule | HB15, BL11 | 6p23 | |
| CD84 | CD84 molecule | SLAMF5, hCD84, mCD84 | 1q24 | |
| LILRB3 | leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3 | LIR-3, HL9, ILT5, LIR3, CD85a | 19q13.4 | |
| LILRA6 | leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6 | LILRB6 | ILT8, CD85b | 19q13.4 |
| LILRB5 | leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 5 | LIR-8, LIR8, CD85c | 19q13.4 | |
| LILRB2 | leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 2 | LIR-2, ILT4, MIR-10, LIR2, CD85d, MIR10 | 19q13.4 | |
| LILRA3 | leukocyte immunoglobulin-like receptor, subfamily A (without TM domain), member 3 | LIR-4, HM43, ILT6, HM31, LIR4, CD85e | 19q13.4 | |
| LILRA5 | leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 5 | LILRB7 | ILT11, LIR9, CD85, CD85f | 19q13.4 |
| LILRA4 | leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 4 | ILT7, CD85g | 19q13.4 | |
| LILRA2 | leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 2 | LIR-7, ILT1, CD85h, LIR7 | 19q13.4 | |
| LILRA1 | leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 1 | LIR-6, CD85i, LIR6 | 19q13.4 | |
| LILRB1 | leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 1 | LIR-1, ILT2, MIR-7, CD85, LIR1, CD85j | 19q13.4 | |
| LILRB4 | leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 4 | LIR-5, ILT3, HM18, LIR5, CD85k | 19q13.4 | |
| LILRP1 | leukocyte immunoglobulin-like receptor pseudogene 1 | ILT9, CD85l, LILRA6P | 19q13.4 | |
| LILRP2 | leukocyte immunoglobulin-like receptor pseudogene 2 | ILT10, CD85m | 19q13.4 | |
| CD86 | CD86 molecule | CD28LG2 | B7.2, B7-2 | 3q21 |
| PLAUR | plasminogen activator, urokinase receptor | URKR, UPAR, CD87 | 19q13 | |
| C5AR1 | complement component 5a receptor 1 | C5R1 | C5A, C5AR, CD88 | 19q13.3-q13.4 |
| FCAR | Fc fragment of IgA, receptor for | CD89 | 19q13.42 | |
| THY1 | Thy-1 cell surface antigen | CD90 | 11q23.3 | |
| LRP1 | low density lipoprotein receptor-related protein 1 | APR, A2MR | LRP, CD91, LRP1A | 12q13.3 |
| SLC44A1 | solute carrier family 44, member 1 | CDW92 | CDw92, CTL1, CHTL1, CD92 | 9q31.2 |
| CD93 | CD93 molecule | MXRA4, C1QR1 | C1qRP, C1qR(P), dJ737E23.1, CDw93, ECSM3 | 20p11.21 |
| KLRD1 | killer cell lectin-like receptor subfamily D, member 1 | CD94 | 12p13 | |
| FAS | Fas cell surface death receptor | FAS1, APT1, TNFRSF6 | CD95, APO-1 | 10q24.1 |
| CD96 | CD96 molecule | TACTILE | 3p13-q13.2 | |
| CD97 | CD97 molecule | TM7LN1 | 19p13 | |
| SLC7A5 | solute carrier family 7 (amino acid transporter light chain, L system), member 5 | LAT1, E16, D16S469E, MPE16, CD98 | 16q24.3 | |
| CD99 | CD99 molecule | MIC2 | Xp22.32 and Yp11.3 | |
| SEMA4D | sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D | SEMAJ, C9orf164 | CD100, coll-4, FLJ39737 | 9q22-q31 |
| CD101 | CD101 molecule | IGSF2 | V7 | 1p13 |
| ICAM2 | intercellular adhesion molecule 2 | CD102 | 17q23.3 | |
| ITGAE | integrin, alpha E (antigen CD103, human mucosal lymphocyte antigen 1; alpha polypeptide) | CD103, HUMINAE | 17p13 | |
| ITGB4 | integrin, beta 4 | CD104 | 17q11-qter | |
| ENG | endoglin | ORW1, ORW | END, HHT1, CD105 | 9q34.11 |
| VCAM1 | vascular cell adhesion molecule 1 | CD106 | 1p32-p31 | |
| LAMP1 | lysosomal-associated membrane protein 1 | CD107a | 13q34 | |
| LAMP2 | lysosomal-associated membrane protein 2 | CD107b | Xq24-q25 | |
| SEMA7A | semaphorin 7A, GPI membrane anchor (John Milton Hagen blood group) | SEMAL | H-Sema-L, CD108 | 15q22.3-q23 |
| CD109 | CD109 molecule | FLJ38569, DKFZp762L1111, CPAMD7 | 6q14.1 | |
| MPL | myeloproliferative leukemia virus oncogene | CD110, TPOR | 1p34 | |
| PVRL1 | poliovirus receptor-related 1 (herpesvirus entry mediator C) | HVEC, ED4 | PRR, PRR1, PVRR1, SK-12, HIgR, CLPED1, CD111, OFC7 | 11q23-q24 |
| PVRL2 | poliovirus receptor-related 2 (herpesvirus entry mediator B) | HVEB | PVRR2, PRR2, CD112 | 19q13.32 |
| PVRL3 | poliovirus receptor-related 3 | nectin-3, PPR3, PVRR3, DKFZP566B0846, CDw113, CD113 | 3q13 | |
| CSF3R | colony stimulating factor 3 receptor (granulocyte) | CD114 | GCSFR | 1p35-p34.3 |
| CSF1R | colony stimulating factor 1 receptor | FMS | C-FMS, CSFR, CD115 | 5q32 |
| CSF2RA | colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage) | CSF2R | CD116 | Xp22.32 and Yp11.3 |
| KIT | v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog | PBT | CD117, SCFR, C-Kit | 4q11-q12 |
| LIFR | leukemia inhibitory factor receptor alpha | CD118 | 5p13-p12 | |
| IFNGR1 | interferon gamma receptor 1 | IFNGR | CD119 | 6q23-q24 |
| TNFRSF1A | tumor necrosis factor receptor superfamily, member 1A | TNFR1 | TNF-R, TNFAR, TNFR60, TNF-R-I, CD120a, TNF-R55 | 12p13.2 |
| TNFRSF1B | tumor necrosis factor receptor superfamily, member 1B | TNFR2 | TNFBR, TNFR80, TNF-R75, TNF-R-II, p75, CD120b | 1p36.22 |
| IL1R1 | interleukin 1 receptor, type I | IL1R, IL1RA | D2S1473, CD121A | 2q12 |
| IL1R2 | interleukin 1 receptor, type II | IL1RB | CD121b | 2q12 |
| IL2RB | interleukin 2 receptor, beta | IL15RB | CD122 | 22q13 |
| IL3RA | interleukin 3 receptor, alpha (low affinity) | CD123 | Xp22.3 and Yp13.3 | |
| IL4R | interleukin 4 receptor | CD124 | 16p12.1-p11.2 | |
| IL5RA | interleukin 5 receptor, alpha | IL5R | CDw125, CD125 | 3p26-p24 |
| IL6R | interleukin 6 receptor | CD126 | 1q21 | |
| IL7R | interleukin 7 receptor | CD127 | 5p13 | |
| CXCR1 | chemokine (C-X-C motif) receptor 1 | CMKAR1, IL8RA | CKR-1, CDw128a, CD181 | 2q35 |
| IL9R | interleukin 9 receptor | CD129 | Xq28 and Yq12 | |
| IL6ST | interleukin 6 signal transducer (gp130, oncostatin M receptor) | GP130, CD130 | 5q11.2 | |
| CSF2RB | colony stimulating factor 2 receptor, beta, low-affinity (granulocyte-macrophage) | IL3RB | IL5RB, CD131 | 22q12.2-q13.1 |
| IL2RG | interleukin 2 receptor, gamma | SCIDX1, IMD4, CIDX | CD132 | Xq13 |
| PROM1 | prominin 1 | PROML1, MCDR2, STGD4 | AC133, CD133, RP41 | 4p15 |
| TNFRSF4 | tumor necrosis factor receptor superfamily, member 4 | TXGP1L | ACT35, OX40, CD134 | 1p36 |
| FLT3 | fms-related tyrosine kinase 3 | STK1, FLK2, CD135 | 13q12 | |
| MST1R | macrophage stimulating 1 receptor (c-met-related tyrosine kinase) | RON, PTK8 | CDw136, CD136 | 3p21 |
| TNFRSF9 | tumor necrosis factor receptor superfamily, member 9 | ILA | CD137, 4-1BB | 1p36 |
| SDC1 | syndecan 1 | SDC | CD138, syndecan, SYND1 | 2p24.1 |
| PDGFRA | platelet-derived growth factor receptor, alpha polypeptide | CD140a, PDGFR2 | 4q12 | |
| PDGFRB | platelet-derived growth factor receptor, beta polypeptide | PDGFR | JTK12, CD140b, PDGFR1 | 5q33.1 |
| THBD | thrombomodulin | CD141 | 20p12-cen | |
| F3 | coagulation factor III (thromboplastin, tissue factor) | CD142 | 1p22-p21 | |
| ACE | angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 | DCP1 | ACE1, CD143 | 17q23.3 |
| CDH5 | cadherin 5, type 2 (vascular endothelium) | 7B4, CD144 | 16q22.1 | |
| MCAM | melanoma cell adhesion molecule | MUC18, CD146 | 11q23.3 | |
| BSG | basigin (Ok blood group) | OK | EMMPRIN, CD147 | 19p13.3 |
| PTPRJ | protein tyrosine phosphatase, receptor type, J | DEP1, HPTPeta, CD148 | 11p11.2 | |
| SLAMF1 | signaling lymphocytic activation molecule family member 1 | SLAM | CD150 | 1q23.3 |
| CD151 | CD151 molecule (Raph blood group) | SFA-1, PETA-3, TSPAN24, RAPH | 11p15.5 | |
| CTLA4 | cytotoxic T-lymphocyte-associated protein 4 | CELIAC3 | CD152, CD, GSE, CD28, ICOS | 2q33 |
| PVR | poliovirus receptor | PVS | CD155, HVED, Necl-5, NECL5, Tage4 | 19q13.2 |
| ADAM8 | ADAM metallopeptidase domain 8 | CD156, MS2 | 10q26.3 | |
| ADAM17 | ADAM metallopeptidase domain 17 | TACE | cSVP, CD156B | 2p25 |
| ADAM10 | ADAM metallopeptidase domain 10 | kuz, MADM, HsT18717, CD156c | 15q2 | |
| BST1 | bone marrow stromal cell antigen 1 | CD157 | 4p15 | |
| KIR2DL1 | killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1 | cl-42, nkat1, 47.11, p58.1, CD158A | 19q13.4 | |
| KIR2DL2 | killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 2 | cl-43, nkat6, CD158B1, CD158k | 19q13.4 GRCh37 novel patch | |
| KIR2DL3 | killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3 | cl-6, nkat2, nkat2a, nkat2b, p58, CD158B2 | 19q13.4 | |
| KIR3DP1 | killer cell immunoglobulin-like receptor, three domains, pseudogene 1 | KIRX, KIR48, KIR2DS6, KIR3DS2P, CD158C | 19q13.4 | |
| KIR2DL4 | killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4 | 103AS, 15.212, CD158D | 19q13.4 | |
| KIR3DL1 | killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1 | KIR | cl-2, NKB1, cl-11, nkat3, NKB1B, AMB11, CD158e1/2, CD158e1, CD158e2 | 19q13.4 |
| KIR2DL5A | killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 5A | KIR2DL5.1, KIR2DL5, CD158F | 19q13.4 GRCh37 novel patch | |
| KIR2DS5 | killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 5 | nkat9, CD158G | 19q13.4 GRCh37 novel patch | |
| KIR2DS1 | killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 1 | EB6ActI, EB6ActII, CD158H | 19q13.4 GRCh37 novel patch | |
| KIR2DS4 | killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 4 | cl-39, KKA3, nkat8, CD158i | 19q13.4 | |
| KIR2DS2 | killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 2 | cl-49, nkat5, 183ActI, CD158J | 19q13.4 GRCh37 novel patch | |
| KIR3DL2 | killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2 | cl-5, nkat4, nkat4a, nkat4b, CD158K | 19q13.4 | |
| KIR3DL3 | killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 3 | KIRC1, KIR3DL7, KIR44, CD158z | 19q13.4 | |
| KLRC1 | killer cell lectin-like receptor subfamily C, member 1 | NKG2 | NKG2-A, NKG2-B, CD159a | 12p13 |
| KLRC2 | killer cell lectin-like receptor subfamily C, member 2 | NKG2-C, CD159c | 12p13 | |
| CD160 | CD160 molecule | BY55, NK1, NK28 | 1q21.2 | |
| KLRB1 | killer cell lectin-like receptor subfamily B, member 1 | NKR | CD161, NKR-P1, NKR-P1A, hNKR-P1A, CLEC5B | 12p13 |
| SELPLG | selectin P ligand | PSGL-1, CD162 | 12q24 | |
| CD163 | CD163 molecule | M130, MM130 | 12p13 | |
| CD164 | CD164 molecule, sialomucin | MUC-24, MGC-24 | 6q21 | |
| ALCAM | activated leukocyte cell adhesion molecule | CD166, MEMD | 3q13.1 | |
| DDR1 | discoidin domain receptor tyrosine kinase 1 | NTRK4, PTK3A, NEP, CAK, EDDR1 | RTK6, CD167 | 6p21.33 |
| HMMR | hyaluronan-mediated motility receptor (RHAMM) | RHAMM, CD168 | 5q33.2-qter | |
| SIGLEC1 | sialic acid binding Ig-like lectin 1, sialoadhesin | SN | SIGLEC-1, CD169, FLJ00051, FLJ00055, FLJ00073, FLJ32150, dJ1009E24.1, sialoadhesin | 20p13 |
| L1CAM | L1 cell adhesion molecule | HSAS1, SPG1, HSAS, MASA, MIC5, S10 | CD171 | Xq28 |
| SIRPA | signal-regulatory protein alpha | PTPNS1 | SHPS1, SIRP, MYD-1, BIT, P84, SHPS-1, SIRPalpha, CD172a, SIRPalpha2, MFR, SIRP-ALPHA-1 | 20p13 |
| SIRPB1 | signal-regulatory protein beta 1 | SIRP-BETA-1, CD172b | 20p13 | |
| SIRPG | signal-regulatory protein gamma | SIRPB2 | bA77C3.1, SIRP-B2, SIRPgamma, CD172g | 20p13 |
| FUT3 | fucosyltransferase 3 (galactoside 3(4)-L-fucosyltransferase, Lewis blood group) | LE | CD174 | 19p13.3 |
| CD177 | CD177 molecule | PRV1, HNA2A, NB1 | 19q13.2 | |
| FASLG | Fas ligand (TNF superfamily, member 6) | APT1LG1, TNFSF6 | FasL, CD178 | 1q23 |
| VPREB1 | pre-B lymphocyte 1 | VpreB, CD179A | 22q11.2 | |
| IGLL1 | immunoglobulin lambda-like polypeptide 1 | IGLL | IGVPB, IGL5, 14.1, CD179B | 22q11.23 |
| CD180 | CD180 molecule | LY64 | RP105, Ly78 | 5q12 |
| CXCR2 | chemokine (C-X-C motif) receptor 2 | IL8RB | CMKAR2, CD182 | 2q35 |
| CXCR3 | chemokine (C-X-C motif) receptor 3 | GPR9 | CKR-L2, CMKAR3, IP10-R, MigR, CD183 | Xq13 |
| CXCR4 | chemokine (C-X-C motif) receptor 4 | LESTR, NPY3R, HM89, NPYY3R, D2S201E, fusin, HSY3RR, NPYR, CD184 | 2q21 | |
| CXCR5 | chemokine (C-X-C motif) receptor 5 | BLR1 | MDR15, CD185 | 11q23.3 |
| CXCR6 | chemokine (C-X-C motif) receptor 6 | TYMSTR, STRL33, BONZO, CD186 | 3p21 | |
| CCR1 | chemokine (C-C motif) receptor 1 | SCYAR1, CMKBR1 | CKR-1, MIP1aR, CD191 | 3p21 |
| CCR2 | chemokine (C-C motif) receptor 2 | CMKBR2 | CC-CKR-2, CKR2, MCP-1-R, CD192, FLJ78302 | 3p21 |
| CCR3 | chemokine (C-C motif) receptor 3 | CMKBR3 | CC-CKR-3, CKR3, CD193 | 3p21.3 |
| CCR4 | chemokine (C-C motif) receptor 4 | CC-CKR-4, CMKBR4, CKR4, k5-5, ChemR13, CD194 | 3p24-p21.3 | |
| CCR5 | chemokine (C-C motif) receptor 5 (gene/pseudogene) | CMKBR5 | CKR-5, CC-CKR-5, CKR5, CD195, IDDM22 | 3p21 |
| CCR6 | chemokine (C-C motif) receptor 6 | STRL22 | CKR-L3, GPR-CY4, CMKBR6, GPR29, DRY-6, DCR2, BN-1, CD196 | 6q27 |
| CCR7 | chemokine (C-C motif) receptor 7 | CMKBR7, EBI1 | BLR2, CDw197, CD197 | 17q12-q21.2 |
| CCR8 | chemokine (C-C motif) receptor 8 | CMKBRL2, CMKBR8 | CY6, TER1, CKR-L1, GPR-CY6, CDw198 | 3p22 |
| CCR9 | chemokine (C-C motif) receptor 9 | GPR28 | GPR-9-6, CDw199 | 3p21.31 |
| CD200 | CD200 molecule | MOX1, MOX2 | MRC, OX-2 | 3 |
| PROCR | protein C receptor, endothelial | EPCR, CCD41, CD201 | 20q11.2 | |
| TEK | TEK tyrosine kinase, endothelial | VMCM | TIE2, TIE-2, VMCM1, CD202b | 9p21 |
| ENPP3 | ectonucleotide pyrophosphatase/phosphodiesterase 3 | PDNP3 | PD-IBETA, gp130RB13-6, B10, CD203c | 6q22 |
| MSR1 | macrophage scavenger receptor 1 | SCARA1, CD204 | 8p22 | |
| LY75 | lymphocyte antigen 75 | DEC-205, CLEC13B, CD205 | 2q24 | |
| MRC1 | mannose receptor, C type 1 | MRC1L1 | CLEC13D, CD206, bA541I19.1, CLEC13DL | 10p13 |
| CD207 | CD207 molecule, langerin | Langerin, CLEC4K | 2p13 | |
| LAMP3 | lysosomal-associated membrane protein 3 | LAMP, TSC403, DC-LAMP, DCLAMP, CD208 | 3q26.3-q27 | |
| CD209 | CD209 molecule | DC-SIGN, CDSIGN, DC-SIGN1, CLEC4L | 19p13 | |
| CLEC4M | C-type lectin domain family 4, member M | CD209L, CD299 | HP10347, DC-SIGNR, LSIGN, DCSIGNR, DC-SIGN2 | 19p13 |
| IL10RA | interleukin 10 receptor, alpha | IL10R | HIL-10R, CDW210A, CD210a, CD210 | 11q23 |
| IL12RB1 | interleukin 12 receptor, beta 1 | IL12RB | CD212 | 19p13.1 |
| IL13RA1 | interleukin 13 receptor, alpha 1 | IL-13Ra, NR4, CD213a1 | Xq24 | |
| IL13RA2 | interleukin 13 receptor, alpha 2 | IL-13R, IL13BP, CD213a2, CT19 | Xq13.1-q28 | |
| IL15RA | interleukin 15 receptor, alpha | CD215, IL-15RA | 10p15.1 | |
| IL17RA | interleukin 17 receptor A | IL17R | hIL-17R, IL-17RA, CDw217, CD217 | 22q11.1 |
| IL18R1 | interleukin 18 receptor 1 | IL1RRP, IL-1Rrp, CD218a | 2q12 | |
| IL18RAP | interleukin 18 receptor accessory protein | AcPL, CD218b | 2q12.1 | |
| INSR | insulin receptor | CD220 | 19p13.3-p13.2 | |
| IGF1R | insulin-like growth factor 1 receptor | JTK13, CD221, IGFIR, MGC18216, IGFR | 15q26.3 | |
| IGF2R | insulin-like growth factor 2 receptor | CD222, MPRI, MPR1, CIMPR, M6P-R | 6q25-q27 | |
| LAG3 | lymphocyte-activation gene 3 | CD223 | 12p13.3 | |
| GGT1 | gamma-glutamyltransferase 1 | GGT | D22S672, D22S732, CD224 | 22q11.23 |
| IFITM1 | interferon induced transmembrane protein 1 | IFI17 | 9-27, CD225 | 11p15.5 |
| CD226 | CD226 molecule | DNAM-1, DNAM1, PTA1, TLiSA1 | 18q22.3 | |
| MUC1 | mucin 1, cell surface associated | PUM | CD227, PEM | 1q22 |
| MFI2 | antigen p97 (melanoma associated) identified by monoclonal antibodies 133.2 and 96.5 | CD228, FLJ38863, MAP97, MGC4856, MTF1 | 3q28-q29 | |
| LY9 | lymphocyte antigen 9 | CD229, mLY9, SLAMF3, hly9 | 1q23.3 | |
| PRNP | prion protein | PRIP, GSS, CJD | CD230, PRP, AltPrP | 20p13 |
| TSPAN7 | tetraspanin 7 | MXS1, TM4SF2, MRX58 | DXS1692E, TALLA-1, A15, CD231 | Xp11.4 |
| PLXNC1 | plexin C1 | VESPR, CD232 | 12q23 | |
| SLC4A1 | solute carrier family 4, anion exchanger, member 1 (erythrocyte membrane protein band 3, Diego blood group) | EPB3, AE1, DI, WD | RTA1A, CD233, FR, SW, WR | 17q21.31 |
| DARC | Duffy blood group, chemokine receptor | FY | CCBP1, GPD, Dfy, CD234 | 1q21-q22 |
| GYPA | glycophorin A (MNS blood group) | MNS | GPA, MN, CD235a | 4q31.21 |
| GYPB | glycophorin B (MNS blood group) | MNS | GPB, SS, CD235b | 4q31.21 |
| GYPC | glycophorin C (Gerbich blood group) | GPC, GYPD, Ge, CD236, CD236R | 2q14-q21 | |
| KEL | Kell blood group, metallo-endopeptidase | ECE3, CD238 | 7q33 | |
| BCAM | basal cell adhesion molecule (Lutheran blood group) | LU | CD239 | 19q12-q13 |
| RHCE | Rh blood group, CcEe antigens | RH | CD240CE | 1p36.11 |
| RHD | Rh blood group, D antigen | RH | Rh30a, Rh4, RhPI, RhII, DIIIc, CD240D | 1p36.11 |
| RHAG | Rh-associated glycoprotein | RH50A, CD241, SLC42A1 | 6p12.3 | |
| ICAM4 | intercellular adhesion molecule 4 (Landsteiner-Wiener blood group) | LW | CD242 | 19p13.2-cen |
| ABCB1 | ATP-binding cassette, sub-family B (MDR/TAP), member 1 | PGY1, MDR1, CLCS | P-gp, CD243, GP170, ABC20 | 7q21.12 |
| CD244 | CD244 molecule, natural killer cell receptor 2B4 | 2B4, NAIL, NKR2B4, Nmrk, SLAMF4 | 1q23.1 | |
| ALK | anaplastic lymphoma receptor tyrosine kinase | CD246 | 2p23 | |
| CD247 | CD247 molecule | CD3Z | CD3H, CD3Q | 1q24.2 |
| CD248 | CD248 molecule, endosialin | CD164L1 | TEM1 | 11q13 |
| ENPEP | glutamyl aminopeptidase (aminopeptidase A) | gp160, CD249 | 4q25 | |
| TNFSF4 | tumor necrosis factor (ligand) superfamily, member 4 | TXGP1 | OX-40L, gp34, CD252 | 1q25 |
| TNFSF10 | tumor necrosis factor (ligand) superfamily, member 10 | TRAIL, Apo-2L, TL2, CD253 | 3q26 | |
| TNFSF11 | tumor necrosis factor (ligand) superfamily, member 11 | TRANCE, RANKL, OPGL, ODF, CD254 | 13q14 | |
| TNFSF13 | tumor necrosis factor (ligand) superfamily, member 13 | APRIL, CD256 | 17p13.1 | |
| TNFSF13B | tumor necrosis factor (ligand) superfamily, member 13b | TNFSF20 | BAFF, THANK, BLYS, TALL-1, TALL1, CD257 | 13q32-q34 |
| TNFSF14 | tumor necrosis factor (ligand) superfamily, member 14 | LIGHT, LTg, HVEM-L, CD258 | 19p13.3 | |
| TNFRSF10A | tumor necrosis factor receptor superfamily, member 10a | DR4, Apo2, TRAILR-1, CD261 | 8p21 | |
| TNFRSF10B | tumor necrosis factor receptor superfamily, member 10b | DR5, KILLER, TRICK2A, TRAIL-R2, TRICKB, CD262 | 8p22-p21 | |
| TNFRSF10C | tumor necrosis factor receptor superfamily, member 10c, decoy without an intracellular domain | DcR1, TRAILR3, LIT, TRID, CD263 | 8p22-p21 | |
| TNFRSF10D | tumor necrosis factor receptor superfamily, member 10d, decoy with truncated death domain | DcR2, TRUNDD, TRAILR4, CD264 | 8p21 | |
| TNFRSF11A | tumor necrosis factor receptor superfamily, member 11a, NFKB activator | RANK, CD265 | 18q22.1 | |
| TNFRSF12A | tumor necrosis factor receptor superfamily, member 12A | FN14, TweakR, CD266 | 16p13.3 | |
| TNFRSF13B | tumor necrosis factor receptor superfamily, member 13B | TACI, CD267 | 17p11.2 | |
| TNFRSF13C | tumor necrosis factor receptor superfamily, member 13C | BAFFR, CD268 | 22q13.1-q13.3 | |
| TNFRSF17 | tumor necrosis factor receptor superfamily, member 17 | BCMA | BCM, CD269, TNFRSF13A | 16p13.1 |
| TNFRSF14 | tumor necrosis factor receptor superfamily, member 14 | HVEM, ATAR, TR2, LIGHTR, HVEA, CD270 | 1p36.32 | |
| NGFR | nerve growth factor receptor | TNFRSF16, CD271, p75NTR | 17q21-q22 | |
| BTLA | B and T lymphocyte associated | BTLA1, CD272 | 3q13.2 | |
| PDCD1LG2 | programmed cell death 1 ligand 2 | PD-L2, Btdc, PDL2, bA574F11.2, CD273, B7-DC | 9p24.2 | |
| CD274 | CD274 molecule | PDCD1LG1 | B7-H, B7H1, PD-L1, PDL1, B7-H1 | 9p24.1 |
| ICOSLG | inducible T-cell co-stimulator ligand | ICOSL | KIAA0653, GL50, B7-H2, B7RP-1, B7H2, B7RP1, ICOS-L, CD275 | 21q22.3 |
| CD276 | CD276 molecule | B7-H3, B7H3, B7RP-2 | 15q23-q24 | |
| BTN3A1 | butyrophilin, subfamily 3, member A1 | BT3.1, BTF5, CD277 | 6p22.1 | |
| ICOS | inducible T-cell co-stimulator | AILIM, CD278 | 2q33 | |
| PDCD1 | programmed cell death 1 | CD279, PD1 | 2q37.3 | |
| MRC2 | mannose receptor, C type 2 | KIAA0709, ENDO180, CLEC13E, CD280 | 17q23 | |
| TLR1 | toll-like receptor 1 | rsc786, KIAA0012, CD281 | 4p14 | |
| TLR2 | toll-like receptor 2 | TIL4, CD282 | 4q32 | |
| TLR3 | toll-like receptor 3 | CD283 | 4q35 | |
| TLR4 | toll-like receptor 4 | hToll, CD284, TLR-4, ARMD10 | 9q33.1 | |
| TLR6 | toll-like receptor 6 | CD286 | 4p16.1 | |
| TLR8 | toll-like receptor 8 | CD288 | Xp22 | |
| TLR9 | toll-like receptor 9 | CD289 | 3p21.3 | |
| TLR10 | toll-like receptor 10 | CD290 | 4p14 | |
| BMPR1A | bone morphogenetic protein receptor, type IA | ACVRLK3 | ALK3, CD292 | 10q22.3 |
| BMPR1B | bone morphogenetic protein receptor, type IB | ALK6, CDw293 | 4q23-q24 | |
| PTGDR2 | prostaglandin D2 receptor 2 | GPR44 | CRTH2, CD294, DP2 | 11q12-q13.3 |
| LEPR | leptin receptor | OBR, CD295 | 1p31 | |
| ART1 | ADP-ribosyltransferase 1 | ART2, CD296 | 11p15 | |
| ART4 | ADP-ribosyltransferase 4 (Dombrock blood group) | DO | DOK1, CD297 | 12q13.2-q13.3 |
| ATP1B3 | ATPase, Na+/K+ transporting, beta 3 polypeptide | FLJ29027, CD298 | 3q23 | |
| CD300A | CD300a molecule | Irp60, CMRF35H, CMRF-35-H9, IRC1, IRC2, IGSF12 | 17q25.2 | |
| CD300C | CD300c molecule | CMRF35, LIR, CMRF-35A, CMRF35A, IGSF16 | 17q25.2 | |
| CD300E | CD300e molecule | CD300LE | IREM2, CLM2 | 17q25.1 |
| CLEC10A | C-type lectin domain family 10, member A | CLECSF13, CLECSF14 | HML2, HML, CD301 | 17p13.2 |
| CD302 | CD302 molecule | DCL-1, KIAA0022, BIMLEC, CLEC13A | 2q24.2 | |
| CLEC4C | C-type lectin domain family 4, member C | CLECSF11, CLECSF7 | HECL, DLEC, BDCA2, CD303 | 12p13.2-p12.3 |
| NRP1 | neuropilin 1 | NRP, VEGF165R, CD304 | 10p12 | |
| LAIR1 | leukocyte-associated immunoglobulin-like receptor 1 | CD305 | 19q13.4 | |
| LAIR2 | leukocyte-associated immunoglobulin-like receptor 2 | CD306 | 19q13.4 | |
| FCRL1 | Fc receptor-like 1 | FCRH1, IRTA5, IFGP1, CD307a | 1q21-q22 | |
| FCRL2 | Fc receptor-like 2 | SPAP1 | FCRH2, IRTA4, CD307b | 1q23.1 |
| FCRL3 | Fc receptor-like 3 | FCRH3, IRTA3, IFGP3, SPAP2a, SPAP2, SPAP2b, SPAP2c, SPAP2d, SPAP2e, CD307c | 1q21-q22 | |
| FCRL4 | Fc receptor-like 4 | FCRH4, IRTA1, IGFP2, CD307d | 1q21 | |
| FCRL5 | Fc receptor-like 5 | FCRH5, IRTA2, BXMAS1, CD307e | 1q21 | |
| KDR | kinase insert domain receptor (a type III receptor tyrosine kinase) | FLK1, VEGFR, VEGFR2, CD309 | 4q11-q12 | |
| EMR2 | egf-like module containing, mucin-like, hormone receptor-like 2 | CD312 | 19p13.1 | |
| KLRK1 | killer cell lectin-like receptor subfamily K, member 1 | D12S2489E | NKG2D, KLR, NKG2-D, CD314 | 12p13.2-p12.3 |
| PTGFRN | prostaglandin F2 receptor inhibitor | FPRP, EWI-F, CD9P-1, FLJ11001, KIAA1436, SMAP-6, CD315 | 1p13.1 | |
| BST2 | bone marrow stromal cell antigen 2 | CD317, tetherin | 19p13.2 | |
| CDCP1 | CUB domain containing protein 1 | CD318, SIMA135 | 3p21.3 | |
| SLAMF7 | SLAM family member 7 | CRACC, 19A, CS1, CD319 | 1q23.1-q24.1 | |
| CD320 | CD320 molecule | 8D6, 8D6A | 19p13.3-p13.2 | |
| F11R | F11 receptor | JAM1 | PAM-1, JCAM, JAM-1, JAM-A, JAMA, CD321 | 1q21.2-q21.3 |
| JAM2 | junctional adhesion molecule 2 | C21orf43 | VE-JAM, JAM-B, JAMB, CD322 | 21q21.2 |
| CDH1 | cadherin 1, type 1, E-cadherin (epithelial) | UVO | uvomorulin, CD324 | 16q22.1 |
| CDH2 | cadherin 2, type 1, N-cadherin (neuronal) | NCAD | CDHN, CD325 | 18q12.1 |
| EPCAM | epithelial cell adhesion molecule | M4S1, MIC18, TACSTD1 | Ly74, TROP1, GA733-2, EGP34, EGP40, EGP-2, KSA, CD326, Ep-CAM, HEA125, KS1/4, MK-1, MH99, MOC31, 323/A3, 17-1A, TACST-1, CO-17A, ESA | 2p21 |
| SIGLEC7 | sialic acid binding Ig-like lectin 7 | SIGLEC19P, SIGLECP2 | SIGLEC-7, p75/AIRM1, QA79, CD328 | 19q13.3 |
| SIGLEC9 | sialic acid binding Ig-like lectin 9 | CD329 | 19q13.3-q13.4 | |
| FGFR1 | fibroblast growth factor receptor 1 | FLT2, KAL2 | H2, H3, H4, H5, CEK, FLG, BFGFR, N-SAM, CD331 | 8p12 |
| FGFR2 | fibroblast growth factor receptor 2 | KGFR, BEK, CFD1, JWS | CEK3, TK14, TK25, ECT1, K-SAM, CD332 | 10q25.3-q26 |
| FGFR3 | fibroblast growth factor receptor 3 | ACH | CEK2, JTK4, CD333 | 4p16.3 |
| FGFR4 | fibroblast growth factor receptor 4 | JTK2, CD334 | 5q33-qter | |
| NCR1 | natural cytotoxicity triggering receptor 1 | LY94 | NK-p46, NKP46, CD335 | 19 |
| NCR2 | natural cytotoxicity triggering receptor 2 | LY95 | NK-p44, CD336 | 6p21.1 |
| NCR3 | natural cytotoxicity triggering receptor 3 | LY117 | 1C7, NKp30, CD337 | 6p21.3 |
| ABCG2 | ATP-binding cassette, sub-family G (WHITE), member 2 | EST157481, MXR, BCRP, ABCP, CD338 | 4q22.1 | |
| JAG1 | jagged 1 | AGS, JAGL1 | AHD, AWS, HJ1, CD339 | 20p12.1-p11.23 |
| ERBB2 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) | NGL | NEU, HER-2, CD340, HER2 | 17q11.2-q12 |
| FZD4 | frizzled family receptor 4 | EVR1 | CD344 | 11q14-q21 |
| FZD9 | frizzled family receptor 9 | FZD3, CD349 | 7q11.23 | |
| FZD10 | frizzled family receptor 10 | CD350 | 12q24.33 | |
| FCAMR | Fc receptor, IgA, IgM, high affinity | FKSG87, FCA/MR, CD351 | 1q32.1 | |
| SLAMF6 | SLAM family member 6 | KALI, NTBA, KALIb, Ly108, SF2000, NTB-A, CD352 | 1q23.1 | |
| SLAMF8 | SLAM family member 8 | BLAME, SBBI42, CD353 | 1q23.1 | |
| TREM1 | triggering receptor expressed on myeloid cells 1 | TREM-1, CD354 | 6p21.1 | |
| CRTAM | cytotoxic and regulatory T cell molecule | CD355 | 11q24.1 | |
| TNFRSF18 | tumor necrosis factor receptor superfamily, member 18 | AITR, GITR, CD357 | 1p36.3 | |
| TNFRSF21 | tumor necrosis factor receptor superfamily, member 21 | DR6, CD358 | 6p21.1 | |
| IL21R | interleukin 21 receptor | CD360 | 16p11 | |
| EVI2B | ecotropic viral integration site 2B | D17S376, EVDB, CD361 | 17q11.2 | |
| SDC2 | syndecan 2 | HSPG, HSPG1 | fibroglycan, SYND2, CD362 | 8q22-q23 |
| S1PR1 | sphingosine-1-phosphate receptor 1 | EDG1 | edg-1, D1S3362, CD363 | 1p21 |
| CXCR7 | chemokine (C-X-C motif) receptor 7 | CMKOR1 | RDC1, GPR159 | 2q37.3 |
| IL10RB | interleukin 10 receptor, beta | CRFB4, D21S58, D21S66 | CRF2-4, CDW210B, IL-10R2 | 21q22.11 |
This online database does not include our confidential data. If you would like to create a new gene symbol and name, the only way to confirm it as unique is by contacting us.
